Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma

Figure 3

Evolution of proteinuria. -axis: time (months); 0 = start of first bortezomib administration; -axis: 24 h proteinuria (g/24 h). VTD: bortezomib-thalidomide-dexamethasone; Rd: lenalidomide-dexamethasone; VD: bortezomib-dexamethasone.